Study: Drug-Eluting Stents Still Safer Than Bioresorbable Ones

However, researchers are encouraged by parts of the study that suggest a bright future for the devices that can dissolve inside your arteries.

In the ongoing study of a dissolvable coronary artery stent, Cleveland Clinic researchers suggest that the most recent study results may not paint an accurate picture of the products potential upside. In the study, heart patients who received the Absorb everolimus-eluting bioresorbable vascular scaffold (BVS) fared somewhat worse than those who received the traditional drug-eluting metal stents (DES).
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access